Basic Information

Faculty

• 薬学部

Academic Degree

• 修士（工学）(東京大学)
• 博士（工学）(東京大学)

Academic Resume (Graduate Schools)

• The University of Tokyo, School of Engineering, Department of Chemistry and Biotechnology, 修了
• The University of Tokyo, School of Engineering, Department of Advanced Interdisciplinary Studies, 修了

Research History

• From Dec. 2024, To Present

  Kyoto University, Graduate School of Pharmaceutical Sciences, 講師
• From Jan. 2020, To Nov. 2024

  National Institutes of Biomedical Innovation, Health and Nutrition, Center for Drug Design Research, Research Scientist
• From Jan. 2020, To Nov. 2024

  Kyoto University, Graduate School of Pharmaceutical Sciences, Assistant Professor
• From Oct. 2016, To Dec. 2019

  National Institutes of Biomedical Innovation, Health and Nutrition, Center for Drug Design Research, Project Researcher
• From Apr. 2016, To Oct. 2016

  The University of Tokyo, School of Engineering, Project Researcher
• From Apr. 2013, To Mar. 2016

  The University of Tokyo, School of Engineering, Project Researcher
• From Apr. 2022, To Mar. 2023

  National Institutes of Biomedical Innovation, Health and Nutrition, ヘルス・メディカル連携研究センター, 研究員

Language of Instruction

• Japanese
• English

ID,URL

• ORCID ID

  0000-0002-1450-5873

• J-Global ID

  201801017050753598

• External link

  http://www.pharm.kyoto-u.ac.jp/kunib/en/biopharm/index.html

researchmap URL

• https://researchmap.jp/HirokiAkiba

Research

Research Topics, Overview of the research

• Research Topics

  Optimization of antibody therapeutics and generation of novel pharmaceutical modality based on biologics

• Overview of the research

  I employ chemical and biochemical techniques to optimize and alter the functions of antibody therapeutics.

Research Areas

• Life sciences, Biophysics
• Manufacturing technology (mechanical, electrical/electronic, chemical engineering), Applied biofunctional and bioprocess engineering
• Nanotechnology/Materials, Biochemistry
• Life sciences, Pharmaceuticals - chemistry and drug development

Papers

• Visible light-mediated photocatalytic coupling between tetrazoles and carboxylic acids for biomolecule labelling

  Takuro Matsuoka; Ryosuke Takasaki; Hiroki Akiba; Kosuke Ogata; Akira Hattori; Norihito Arichi; Hideaki Kakeya; Sho Yamasaki; Yasushi Ishihama; Hiroaki Ohno; Shinsuke Inuki

  Chemical Communications, 2025

  
• Conversion of an agonistic anti-TNFR2 biparatopic antibody into an antagonist by insertion of peptide linkers into the hinge region

  Takuya Otsuki; Shigeyuki Matsumoto; Junso Fujita; Tomoko Miyata; Keiichi Namba; Ryo Kanada; Yasushi Okuno; Haruhiko Kamada; Hiroaki Ohno; Hiroki Akiba

  15 Feb. 2025

  
• Generation of antagonistic biparatopic anti-CD30 antibody from an agonistic antibody by precise epitope determination and utilization of structural characteristics of CD30 molecule

  Hiroki Akiba; Tomoko Ise; Reiko Satoh; Yasuhiro Abe; Kouhei Tsumoto; Hiroaki Ohno; Haruhiko Kamada; Satoshi Nagata

  Antibody Therapeutics, 19 Jan. 2025

  Access this paper :

  
• Unveiling the structural mechanisms behind high affinity and selectivity in phosphorylated epitope-specific rabbit antibodies

  Keisuke Kasahara; Raiji Kawade; Makoto Nakakido; Ryo Matsunaga; Hiroki Akiba; Kevin C. Entzminger; Toshiaki Maruyama; Shigeru C.J. Okumura; Jose M.M. Caaveiro; Daisuke Kuroda; Kouhei Tsumoto

  Journal of Biological Chemistry, Nov. 2024

  
• 抗原ペプチドの硫酸化がペプチド一抗体間相互作用に与える影響の熱力学的解析(Thermodynamic analysis of the effect of sulfation on a peptideantibody interaction)

  Miyanabe Kazuhiro; Akiba Hiroki; Takamatsu Yuichiro; Yamashita Takefumi; Jose Caaveiro; Tsumoto Kouhei

  生物物理, Aug. 2017

  
• A Proximity‐Induced Fluorogenic Reaction Triggered by Antibody–Antigen Interactions with Adjacent Epitopes

  Kentaro Nishiyama; Hiroki Akiba; Satoshi Nagata; Kouhei Tsumoto; Haruhiko Kamada; Hiroaki Ohno

  Angewandte Chemie International Edition, 31 May 2023, Corresponding author

  Access this paper :

  
• Development of a 1:1-binding biparatopic anti-TNFR2 antagonist by reducing signaling activity through epitope selection

  Hiroki Akiba; Junso Fujita; Tomoko Ise; Kentaro Nishiyama; Tomoko Miyata; Takayuki Kato; Keiichi Namba; Hiroaki Ohno; Haruhiko Kamada; Satoshi Nagata; Kouhei Tsumoto

  Communications Biology, 27 Sep. 2023, Lead author, Corresponding author

  Access this paper :

  
• Development of a recombinant hepatitis B immunoglobulin derived from B cells collected from healthy individuals administered with hepatitis B virus vaccines: A feasibility study

  Rika A. Furuta; Teruhito Yasui; Takeharu Minamitani; Hiroki Akiba; Chizu Toyoda; Ryutaro Tobita; Kazuta Yasui; Ryota Aminaka; Mikako Masaki; Masahiro Satake

  Transfusion, 29 Apr. 2023

  Access this paper :

  
• Optimization of anti-ADAMTS13 antibodies for the treatment of ADAMTS13-related bleeding disorder in patients receiving circulatory assist device support

  Toshihiro Ito; Takeharu Minamitani; Masaki Hayakawa; Ryota Otsubo; Hiroki Akiba; Kouhei Tsumoto; Masanori Matsumoto; Teruhito Yasui

  Scientific Reports, 16 Nov. 2021

  
• Production of IgG1-based bispecific antibody without extra cysteine residue via intein-mediated protein trans-splicing

  Hiroki Akiba; Tomoko Ise; Satoshi Nagata; Haruhiko Kamada; Hiroaki Ohno; Kouhei Tsumoto

  Scientific Reports, 30 Sep. 2021, Lead author, Corresponding author

  Access this paper :

  
• Epitope-dependent thermodynamic signature of single-domain antibodies against hen egg lysozyme

  Hiroki Akiba; Hiroko Tamura; Jose M M Caaveiro; Kouhei Tsumoto

  The Journal of Biochemistry, 28 Dec. 2021, Lead author

  
• Novel neutralizing human monoclonal antibodies against tetanus neurotoxin

  Takeharu Minamitani; Karin Kiyose; Ryota Otsubo; Toshihiro Ito; Hiroki Akiba; Rika A. Furuta; Tsuyoshi Inoue; Kouhei Tsumoto; Masahiro Satake; Teruhito Yasui

  Scientific Reports, 09 Jun. 2021

  
• The Kg‐antigen, RhAG with a Lys164Gln mutation, gives rise to haemolytic disease of the newborn

  Mitsunobu Tanaka; Takaaki Abe; Takeharu Minamitani; Hiroki Akiba; Toshihiro Horikawa; Ryutaro Tobita; Kazumi Isa; Kenichi Ogasawara; Hideo Takahashi; Hidemi Tateyama; Satomi Tone; Kouhei Tsumoto; Teruhito Yasui; Takafumi Kimura; Yoshihiro Fujimura; Fumiya Hirayama; Yoshihiko Tani; Yoshihiro Takihara

  British Journal of Haematology, 23 Jul. 2020, Peer-reviewed

  
• Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain

  Jinbing Xie; Daniel Gonzalez-Carter; Theofilus A. Tockary; Noriko Nakamura; Yonger Xue; Makoto Nakakido; Hiroki Akiba; Anjaneyulu Dirisala; Xueying Liu; Kazuko Toh; Tao Yang; Zengtao Wang; Shigeto Fukushima; Junjie Li; Sabina Quader; Kouhei Tsumoto; Takanori Yokota; Yasutaka Anraku; Kazunori Kataoka

  ACS Nano, 23 Jun. 2020, Peer-reviewed

  
• 64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time

  Kentaro Fujiwara; Hiroki Akiba; Atsushi B. Tsuji; Hitomi Sudo; Aya Sugyo; Kotaro Nagatsu; Ming-Rong Zhang; Hiroko Iwanari; Osamu Kusano-Arai; Shota Kudo; Chika Kikuchi; Kouhei Tsumoto; Toshimitsu Momose; Takao Hamakubo; Tatsuya Higashi

  Nuclear Medicine Communications, 01 May 2020, Peer-reviewed, Lead author

  
• GPC1 specific CAR-T cells eradicate established solid tumor without adverse effects and synergize with anti-PD-1 Ab.

  Daiki Kato; Tomonori Yaguchi; Takashi Iwata; Yuki Katoh; Kenji Morii; Kinya Tsubota; Yoshiaki Takise; Masaki Tamiya; Haruhiko Kamada; Hiroki Akiba; Kouhei Tsumoto; Satoshi Serada; Tetsuji Naka; Ryohei Nishimura; Takayuki Nakagawa; Yutaka Kawakami

  eLife, 31 Mar. 2020, Peer-reviewed

  
• Computer-guided library generation applied to the optimization of single-domain antibodies

  Akiba H, Tamura H, Caaveiro JMM, Tsumoto K

  Prot. Eng. Des. Selec., Mar. 2020, Peer-reviewed, Lead author

  
• Generation of biparatopic antibody through two step targeting of fragment antibodies on antigen using SpyTag and SpyCatcher

  Akiba H; Takayanagi K; Kusano-Arai O; Iwanari H; Hamakubo T; Tsumoto K

  Biotechnology Reports, Mar. 2020, Peer-reviewed, Lead author

  
• Variantome driven antibody/peptide design via artificial intelligence and distributed cooperative automatic experiment devices

  興野 悠太郎; 鈴木 祥平; 山﨑 昌子; 玉木 聡志; 伊原 頌二; 秋葉 宏樹; 小川 隆

  人工知能学会誌, Jan. 2020, Invited

  
• Development and activities, including immunocomplex formation, of biparatopic antibodies and alternative scaffold proteins

  Hiroki Akiba; Kouhei Tsumoto

  Translational and Regulatory Sciences, Jan. 2020, Peer-reviewed, Invited, Lead author

  
• Structural and thermodynamic basis for the recognition of the substrate-binding cleft on hen egg lysozyme by a single-domain antibody.

  Akiba H; Tamura H; Kiyoshi M; Yanaka S; Sugase K; Caaveiro JMM; Tsumoto K

  Scientific reports, Oct. 2019, Peer-reviewed, Lead author

  Access this paper :

  
• ¹¹¹In-labeled anti-cadherin17 antibody D2101 has potential as a noninvasive imaging probe for diagnosing gastric cancer and lymph-node metastasis.

  Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Akiba H; Iwanari H; Kusano-Arai O; Tsumoto K; Momose T; Hamakubo T; Higashi T

  Annals of nuclear medicine, Oct. 2019, Peer-reviewed

  
• Effect of allotypic variation of human IgG1 on the thermal stability of disulfide-linked knobs-into-holes mutants of the Fc for stable bispecific antibody design

  Akiba H; Satoh R; Nagata S; Tsumoto K

  Antibody Therapeutics, Sep. 2019, Peer-reviewed, Lead author

  
• 新規ラベル化プロテオミクス技術による創薬ターゲット探索技術の開発

  鎌田 春彦; 中山 泰亮; 秋葉 宏樹; 津本 浩平; 西村 翔太; 井上 豪

  電気泳動, Jul. 2019

  
• Structural behavior of keratin-associated protein 8.1 in human hair as revealed by a monoclonal antibody.

  Akiba H; Ikeuchi E; Ganbat J; Fujikawa H; Arai-Kusano O; Iwanari H; Nakakido M; Hamakubo T; Shimomura Y; Tsumoto K

  Journal of structural biology, Aug. 2018, Peer-reviewed, Lead author

  
• Intramolecular H-bonds govern the recognition of a flexible peptide by an antibody.

  Kazuhiro Miyanabe; Hiroki Akiba; Daisuke Kuroda; Makoto Nakakido; Osamu Kusano-Arai; Hiroko Iwanari; Takao Hamakubo; Jose M M Caaveiro; Kouhei Tsumoto

  Journal of biochemistry, 01 Jul. 2018, Peer-reviewed

  
• Tyrosine Sulfation Restricts the Conformational Ensemble of a Flexible Peptide, Strengthening the Binding Affinity for an Antibody.

  Miyanabe K; Yamashita T; Abe Y; Akiba H; Takamatsu Y; Nakakido M; Hamakubo T; Ueda T; Caaveiro JMM; Tsumoto K

  Biochemistry, Jul. 2018, Peer-reviewed

  
• Roles of the disulfide bond between the variable and the constant domains of rabbit immunoglobulin kappa chains in thermal stability and affinity

  Kawade, R.; Akiba, H.; Entzminger, K.; Maruyama, T.; Okumura, C.J.; Tsumoto, K.

  Protein Engineering, Design and Selection, May 2018, Peer-reviewed, Lead author

  
• Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17

  Osamu Kusano-Arai; Hiroko Iwanari; Shota Kudo; Chika Kikuchi; Anna Yui; Hiroki Akiba; Keisuke Matsusaka; Atsushi Kaneda; Masashi Fukayama; Kouhei Tsumoto; Takao Hamakubo

  Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, Feb. 2018, Peer-reviewed

  
• Thermodynamic analyses of amino acid residues at the interface of an antibody B2212A and its antigen roundabout homolog 1

  Anna Yui; Hiroki Akiba; Shota Kudo; Makoto Nakakido; Satoru Nagatoishi; Kouhei Tsumoto

  JOURNAL OF BIOCHEMISTRY, Oct. 2017, Peer-reviewed, Lead author

  
• Use of SpyTag/SpyCatcher to construct bispecific antibodies that target two epitopes of a single antigen

  Kyohei Yumura; Hiroki Akiba; Satoru Nagatoishi; Osamu Kusano-Arai; Hiroko Iwanari; Takao Hamakubo; Kouhei Tsumoto

  JOURNAL OF BIOCHEMISTRY, Sep. 2017, Peer-reviewed

  
• Improved Brain Expression of Anti-Amyloid beta scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer

  Federico Perche; Satoshi Uchida; Hiroki Akiba; Chin-Yu Lin; Masaru Ikegami; Anjaneyulu Dirisala; Toshihiro Nakashima; Keiji Itaka; Kohei Tsumoto; Kazunori Kataoka

  CURRENT ALZHEIMER RESEARCH, 2017, Peer-reviewed

  
• カドヘリン-17ドメイン特異的抗体を用いたイムノトキシンカクテル法の開発

  新井 修; 岩成 宏子; 工藤 翔太; 秋葉 宏樹; 松坂 恵介; 金田 篤志; 深山 正久; 津本 浩平; 浜窪 隆雄

  日本生化学会大会プログラム・講演要旨集, Sep. 2016

  
• Fragment antibodies and their application in drug delivery systems

  秋葉宏樹; 津本浩平

  月刊バイオインダストリー, 2016, Invited

  
• Selective Sensing of Tyrosine Phosphorylation in Peptides Using Terbium(III) Complexes

  Jun Sumaoka; Hiroki Akiba; Makoto Komiyama

  INTERNATIONAL JOURNAL OF ANALYTICAL CHEMISTRY, 2016, Peer-reviewed

  
• Thermodynamics of antibody-antigen interaction revealed by mutation analysis of antibody variable regions

  Hiroki Akiba; Kouhei Tsumoto

  JOURNAL OF BIOCHEMISTRY, Jul. 2015, Peer-reviewed, Lead author

  
• Click Conjugation of a Binuclear Terbium(III) Complex for Real-Time Detection of Tyrosine Phosphorylation

  Hiroki Akiba; Jun Sumaoka; Kouhei Tsumoto; Makoto Komiyama

  ANALYTICAL CHEMISTRY, Apr. 2015, Peer-reviewed, Lead author

  
• Conjugation-free, visual, and quantitative evaluation of inhibitors on protein tyrosine kinases and phosphatases with a luminescent Tb(III) complex

  Hiroki Akiba; Jun Sumaoka; Takao Hamakubo; Makoto Komiyama

  ANALYTICAL AND BIOANALYTICAL CHEMISTRY, May 2014, Peer-reviewed, Lead author

  
• Binuclear Terbium(III) Complex as a Probe for Tyrosine Phosphorylation

  Hiroki Akiba; Jun Sumaoka; Makoto Komiyama

  CHEMISTRY-A EUROPEAN JOURNAL, 2010, Peer-reviewed, Lead author

  
• Selective Detection of Phosphotyrosine in the Presence of Various Phosphate-Containing Biomolecules with the Aid of a Terbium(III) Complex

  Hiroki Akiba; Jun Sumaoka; Makoto Komiyama

  CHEMBIOCHEM, Jul. 2009, Peer-reviewed, Lead author

  

Misc.

• Beyond Borders: Next-generation Technologies for Analytical Chemistry and Drug Development

  Hiroki Akiba; Eisuke Kanao

  YAKUGAKU ZASSHI, 01 Jun. 2025

  
• 京大薬・医薬基盤研の連携による未踏創薬分野の開拓

  大野 浩章; 秋葉 宏樹; 金尾 英佑; 石濱 泰

  MEDCHEM NEWS, Sep. 2024, Peer-reviewed, Invited

  
• Imaging of CDH17-positive gastric cancer xenografts with 64Cu-labeled anti-CDH17 IgG PET

  K. Fujiwara; K. Koyama; K. Suga; M. Takahashi; O. Kusano-Arai; K. Mitsui; H. Akiba; H. Iwanari; K. Tsumoto; T. Hamakubo; T. Momose

  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, Oct. 2015

  
• がん転移に関するLI-cadherin一塩基多型の分子メカニズム

  由井杏奈; 菊池智佳; 郷田秀一郎; 工藤翔太; 秋葉宏樹; 中木戸誠; 黒田大祐; 黒田大祐; 長門石曉; 長門石曉; 新井修; 岩成宏子; 浜窪隆雄; 津本浩平; 津本浩平

  日本生化学会大会(Web), 2019

  
• LI-cadherinの一変異が大腸がんのリンパ節転移に与える影響

  由井杏奈; 菊池智佳; 工藤翔太; 秋葉宏樹; 中木戸誠; 長門石曉; 長門石曉; 新井修; 岩成宏子; 浜窪隆雄; 津本浩平; 津本浩平

  日本がん転移学会学術集会・総会プログラム抄録集, 2018

  

Presentations

• 抗体機能の精密デザインに向けた改変アプローチ

  秋葉宏樹

  第21回ABC-InFO講演会, 16 May 2024, Invited

  
• 1:1結合型バイパラトピック抗体による機能開拓

  秋葉宏樹

  日本薬学会第144年会 シンポジウムS28「境界を超える融合研究：次世代が切り拓く創薬モダリティと分子計測」, 30 Mar. 2024, Invited

  
• 基礎研究と実用化研究のあいだに

  秋葉宏樹

  第３回蛋白質科学会若手の会研究交流会, 04 Jul. 2023, Invited

  
• TNF受容体スーパーファミリーに対するバイパラトピック抗体のデザイン戦略

  秋葉宏樹

  第3回モダリティ創薬デザイン研究会シンポジウム, 03 Feb. 2022, Invited

  
• 医薬品開発に向けたバイパラトピック抗体の架橋機能最適化

  秋葉宏樹

  京都大学インダストリアルデイ2021-XR, 04 Aug. 2021, Invited

  
• 抗体エピトープの特徴付けとバイパラトピック抗体への展開

  秋葉宏樹

  バイオインタラクション研究会 第 11 回ワークショップ, 24 Nov. 2020, Invited

  

Books and Other Publications

• 抗体薬物複合体（ADC）の設計・合成と最新動向

  秋葉宏樹, Contributor, 化学的連結法による抗体ターゲティングシステムの開発

  シーエムシー出版, Oct. 2024

  

Industrial Property Rights

• 特許7101433, 特願2021-552206, エピトープ領域架橋型バイパラトピック抗体、及びそれを製造する方法

  秋葉宏樹; 津本浩平; 永田諭志

  

External funds: Kakenhi

• Development of fragment antibody targeting system based on antigen-templated chemical reaction

  Grant-in-Aid for Scientific Research (C)

  Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related

  Kyoto University

  Hiroki Akiba

  From 01 Apr. 2021, To 31 Mar. 2024, Project Closed

  抗体;コンジュゲート化学;テンプレート反応;低分子抗体;クリックケミストリー;蛍光;抗体工学;抗体薬物複合体

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K06453/
• Redesign of biparatopic antibodies through introduction of functional linkers

  Grant-in-Aid for Scientific Research (B)

  Basic Section 27040:Biofunction and bioprocess engineering-related

  Kyoto University

  秋葉 宏樹

  From 01 Apr. 2024, To 31 Mar. 2028, Granted

  抗体医薬品;コンジュゲート化学;蛋白質工学

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K01270/
• 自然免疫型T細胞の機能を利用した新たな創薬モダリティの創出

  Grant-in-Aid for Scientific Research (B)

  Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related

  Kyoto University

  井貫 晋輔

  From 01 Apr. 2024, To 31 Mar. 2028, Granted

  自然免疫型T細胞;低分子リガンド;コンジュゲート化;ワクチンアジュバント;がん治療モダリティ

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-24K02147/

External funds: others

• 抗体医薬の低分子化と機能化を同時に実現する化学的技術の開発 （2020年度分）

  京都発革新的医療技術研究開発助成事業

  From 01 Apr. 2020, To 31 Mar. 2021

  秋葉　宏樹

Education

Teaching subject(s)

• From 01 Apr. 2025, To 31 Mar. 2026

  Introduction to Organic Chemistry for Drug Discovery

  1026, Spring, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Practical Drug Discovery Science Seminar

  2315, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Advanced Basic Organic Chemistry I

  1209, Fall, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Basic Laboratory Techniques in Organic Chemistry

  1205, Spring, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Introduction to Pharmaceutical Sciences

  6002, Spring, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Introduction to Organic Chemistry for Drug Discovery

  8102, Spring, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Advanced Pharmaceutical Sciences I

  6005, Fall, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Chemistry

  C016, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Chemistry

  A016, Spring, Faculty of Pharmaceutical Sciences, 2
• From 01 Apr. 2025, To 31 Mar. 2026

  Research in Practical Drug Discovery Science

  3214, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2025, To 31 Mar. 2026

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2025, To 31 Mar. 2026

  Pharmaceutical Laboratory II : Organic Chemistry

  C902, Spring, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Laboratory Practice in Practical Drug Discovery Science

  4212, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory Coaching Practice B

  8302, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2024, To 31 Mar. 2025

  Practical Drug Discovery Science Seminar

  2315, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2024, To 31 Mar. 2025

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2024, To 31 Mar. 2025

  Research in Practical Drug Discovery Science

  3214, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research C

  8408, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2024, To 31 Mar. 2025

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Fundamental Chemical Experiments

  N308, Fall, Institute for Liberal Arts and Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Laboratory Practice in Practical Drug Discovery Science

  4212, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice B

  8403, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory Coaching Practice B

  8302, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research B

  8407, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Medicinal Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Research in Practical Drug Discovery Science

  3214, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers B

  8405, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2023, To 31 Mar. 2024

  Practical Drug Discovery Science Seminar

  2315, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Practical Drug Discovery Science Seminar

  2315, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Research in Practical Drug Discovery Science

  3214, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  C906, Fall, Faculty of Pharmaceutical Sciences, 3
• From 01 Apr. 2022, To 31 Mar. 2023

  Laboratory Practice in Practical Drug Discovery Science

  4212, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Research Proposal Writing Practice A

  8402, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  A906, Fall, Faculty of Pharmaceutical Sciences, 4
• From 01 Apr. 2022, To 31 Mar. 2023

  Seminar on Critical Reading of Scientific Papers A

  8404, Year-long, Graduate School of Pharmaceutical Sciences, 2
• From 01 Apr. 2022, To 31 Mar. 2023

  Pharmaceutical Laboratory Coaching Practice A

  8301, Year-long, Graduate School of Pharmaceutical Sciences, 1
• From 01 Apr. 2022, To 31 Mar. 2023

  Medical Frontier Science Research A

  8406, Year-long, Graduate School of Pharmaceutical Sciences, 4
• From Apr. 2021, To Mar. 2022

  Laboratory Practice in Practical Drug Discovery Science

  Year-long, 薬学研究科
• From Apr. 2021, To Mar. 2022

  Research in Practical Drug Discovery Science

  Year-long, 薬学研究科
• From Apr. 2021, To Mar. 2022

  Practical Drug Discovery Science Seminar

  Year-long, 薬学研究科
• From Apr. 2021, To Mar. 2022

  Pharmaceutical Laboratory IV : Biochemistry and Microbiology

  Fall, 薬学部
• From Apr. 2021, To Mar. 2022

  Pharmaceutical Laboratory 4 : Biochemistry and Microbiology

  Fall, 薬学部

Administration

School management (title, position)

• From 01 Apr. 2025, To 31 Mar. 2026

  国際高等教育院 企画評価専門委員会 健康・スポーツ部会 委員

Faculty management (title, position)

• From 01 Apr. 2022, To 31 Mar. 2025

  情報システム委員会　委員
• From 01 Apr. 2022, To 31 Mar. 2025

  環境・安全衛生委員会　委員
• From 01 Apr. 2022, To 31 Mar. 2025

  建物・設備・機器管理運営委員会　委員

Academic, Social Contribution

Committee Memberships

• From Aug. 2022, To Present

  関西支部幹事, 日本化学会生体機能関連化学部会若手の会
• From Jun. 2018, To Present

  将来計画委員会委員, 日本分子イメージング学会